In this Business Finland-backed Intelligent Medical Device Solutions to Global Market (IMD1) Co-Innovation project, a consortium composed of various entities possesses complementary knowledge and skills essential for generating innovative solutions in the field of biomaterials within the healthcare sector.
As a part of this project, Bioretec is dedicated to researching and advancing the understanding of the use of biomaterials in the context of bone fracture fixation. The primary focus revolves around the development of coatings for RemeOs™ magnesium alloys. This innovation aims to enhance our ability to control and direct degradation processes, consequently also broadening the scope of indications for RemeOs™ products.
"Following our recent achievement of market authorization for our RemeOs™ screw in the
Business
Further enquiries
Bioretec in brief
Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of biodegradable orthopedic implants. The company has built unique competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries.
Bioretec is developing the new RemeOs™ product line based on a magnesium alloy and hybrid composite, introducing a new generation of strong biodegradable materials for enhanced surgical outcomes. The RemeOs™ implants are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The combination has the potential to make titanium implants redundant and help clinics reach their
Better healing - Better life. www.bioretec.com
https://news.cision.com/bioretec/r/bioretec-has-received-business-finland-s-r-d-grant-for-developing-coatings-for-the-next-generation-o,c3830670
(c) 2023 Cision. All rights reserved., source